Mar 22, 2023 / 01:00PM GMT
Paul Richard Knight - KeyBanc Capital Markets Inc., Research Division - MD & Senior Analyst
Good morning and this is Paul Knight, the analyst, covering West Pharmaceutical. I'm the analyst covering life science technology at KeyBanc. It's a real pleasure to have with us the management from West here today. Eric Green, CEO; Bernard Birkett, our Chief Financial Officer; and Quintin Lai, our Investor Relations. We have a group of questions we're ready to go with. The audience can ask as well. Now there's a spot on your screen where you can raise your hand and is to put in a question or you can e-mail me at paul.r.knight as well. But we'll kind of have Eric say a few comments first. That's good for you, Eric, and then we'll start to jump into some questions as well. But if you want to give an overview of West and have your view on the world today.
Eric M. Green - West Pharmaceutical Services, Inc. - Chair, President & CEO
Yes. Great, Paul. Thank you for hosting us today, and we're looking forward to the conversation [by Lai Quintin]. Actually, 24 hours ago,
West Pharmaceutical Services Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers